Obesity Surgery

, Volume 28, Issue 7, pp 1966–1973 | Cite as

ABSI (A Body Shape Index) and ARI (Anthropometric Risk Indicator) in Bariatric Surgery. First Application on a Bariatric Cohort and Possible Clinical Use

  • Vincenzo Consalvo
  • Jesse C. Krakauer
  • Nir Y. Krakauer
  • Antonio Canero
  • Mafalda Romano
  • Vincenzo Salsano
Original Contributions



BMI (body mass index) is used to identify candidates for bariatric surgery, with a criterion of BMI ≥ 40. For lesser degrees of obesity, BMI 35–39.9, comorbidities are also considered. A Body Shape Index (ABSI) was derived to correct WC (waist circumference) for BMI and height. ABSI has been shown to be a linear predictor of long-term mortality across the range of BMI. Anthropometric risk indicator (ARI) combines the complementary contributions of BMI and ABSI and further improves mortality hazard prediction. We report for the first time ABSI and ARI for a bariatric surgical cohort at baseline and with 3-year follow-up.


ABSI and BMI were calculated for 101 subjects from our bariatric surgery center database at baseline and after 3 years of follow-up. Raw values for BMI and ABSI were converted to Z scores and ARI values based on sex- and age-specific normals and risk associations from the National Health and Nutrition Examination Survey (NHANES) III sample of the US general population.


Baseline scores for the anthropometric variables BMI and ABSI and the corresponding ARI were all higher than for the NHANES population sample. At 3-year post surgery, all three measures decreased significantly. While baseline BMI did not predict the change in mortality risk by ARI, baseline ABSI did (r = − 0.73), as did baseline ARI (r = − 0.94).


Sleeve gastrectomy lowers ABSI and the associated mortality risk estimated from population studies after 3 years of follow-up. Considering our results, bariatric surgical candidates with BMI in the range of 35 to 39.9 with an increased ABSI-related mortality risk may have considerable survival benefit from bariatric surgery, even in the absence of qualifying comorbidities.

Trial Registration Number



ABSI (A Body Shape Index) ARI (anthropometric risk indicator) Bariatric surgery Indications for bariatric surgery 


Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.


  1. 1.
    Collaboration NCDRF. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet. 2016;387:1377–96.CrossRefGoogle Scholar
  2. 2.
    Wang Y, Lobstein T. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes. 2006;1(1):11–25. Scholar
  3. 3.
    Kivimäki M, Kuosma E, Ferrie JE, et al. Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe. Lancet Public Health. 2017;2(6):e277–85. eCollection 2017 JunCrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    WHO. Global action plan for the prevention and control of noncommunicable diseases 2013–2020. Geneva: World Health Organization; 2013.Google Scholar
  5. 5.
    Global BMI Mortality Collaboration. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet. 2016;388(10046):776–86. Scholar
  6. 6.
    Flegal KM, Kit BK, Orpana H, et al. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013;309(1):71–82.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Berrigan D, et al. BMI and mortality: the limits of epidemiological evidence. Lancet. 2016;388(10046):734–736Google Scholar
  8. 8.
    Nazare JA, Smith JD, Borel AL, et al. Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the international study of prediction of intra-abdominal adiposity and its relationship with cardiometabolic risk/intra-abdominal adiposity. Am J Clin Nutr. 2012 Oct;96(4):714–26. Scholar
  9. 9.
    Shah NR, Braverman ER. Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptin. PLoS One. 2012;7(4):e33308.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Yun CH, Bezerra HG, Wu TH, et al. The normal limits, subclinical significance, related metabolic derangements and distinct biological effects of body site-specific adiposity in relatively healthy population. PLoS One. 2013;8(4):e61997. Scholar
  11. 11.
    Krakauer NY, Krakauer JC. A new body shape index predicts mortality hazard independently of body mass index. PLoS One. 2012;7(7):e39504. Scholar
  12. 12.
    Krakauer JC, Krakauer NY. An Anthropometric risk index based on combining height, weight, waist, and hip measurements. J Obes. 2016;2016:8094275.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    The PLOS Medicine Editors. Observational studies: getting clear about transparency. PLoS Med. 2014;11(8):e1001711. Scholar
  14. 14.
    Krakauer NY, Krakauer JC. Dynamic association of mortality hazard with body shape. PLoS One. 2014;9(2):e88793. Scholar
  15. 15.
    Consalvo V, Salsano V. Three-trocar sleeve gastrectomy vs standard five-trocar technique: a randomized controlled trial. Obes Surg. 2017;27(12):3142–48.
  16. 16.
    WHO. Waist circumference and waist-to-hip ratio: report of a WHO expert consultation. Geneva: WHO; 2008.Google Scholar
  17. 17.
    Pouliot M-C, Desprěs J-P, Lemieux S, et al. Waist circumference and abdominal sigittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994;73(7):460–3. Scholar
  18. 18.
    Lofgren I, Herron K, Zern T, et al. Waist circumference is a better predictor than body mass index of coronary heart disease risk in overweight premenopausal women. J Nutr. 2004;134:1071–6.CrossRefPubMedGoogle Scholar
  19. 19.
    Liu J, Fox CS, Hickson DA, et al. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study. J Clin Endocrinol Metab. 2010;95(12):5419–26. Scholar
  20. 20.
    Krakauer NY, Krakauer JC. Expansion of waist circumference in medical literature: potential clinical application of a body shape index. J Obes Weight Loss Ther. 2014;4:216.CrossRefGoogle Scholar
  21. 21.
    Malara M, Kęska A, Tkaczyk J, et al. Body shape index versus body mass index as correlates of health risk in young healthy sedentary men. J Transl Med. 2015;13(1):75. Scholar
  22. 22.
    Bertoli S, Leone A, Krakauer NY, et al. Association of Body Shape Index (ABSI) with cardio-metabolic risk factors: a cross-sectional study of 6081 Caucasian adults. PLoS One. 2017;12(9):e0185013. Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.General Surgery DepartmentUniversità degli Studi di SalernoFiscianoItaly
  2. 2.Clinique ClementvilleMontpellierFrance
  3. 3.Metro Detroit Diabetes and EndocrinologySouthfieldUSA
  4. 4.Department of Civil EngineeringThe City College of New YorkNew YorkUSA
  5. 5.Azienda Ospadaliero Universitaria San Giovanni di Dio e Ruggi D’AragonaSalernoItaly
  6. 6.Università degli Studi di SalernoFiscianoItaly
  7. 7.Bariatric Surgery DepartmentClinique ClementvilleMontepellierFrance

Personalised recommendations